Intravitreal Faricimab for Aflibercept-Resistant Neovascular Age-Related Macular Degeneration

PURPOSE: To evaluate the short-term effects of intravitreal faricimab (IVF) in treatment-resistant neovascular age-related macular degeneration (nAMD) subjects previously treated with intravitreal aflibercept (IVA). METHODS: A retrospective review was conducted on nAMD patients undergoing IVA therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Rush, Ryan B, Rush, Sloan W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747838/
https://www.ncbi.nlm.nih.gov/pubmed/36532820
http://dx.doi.org/10.2147/OPTH.S395279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747838/
https://www.ncbi.nlm.nih.gov/pubmed/36532820
http://dx.doi.org/10.2147/OPTH.S395279

Ejemplares similares